JP2010539901A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010539901A5 JP2010539901A5 JP2010525831A JP2010525831A JP2010539901A5 JP 2010539901 A5 JP2010539901 A5 JP 2010539901A5 JP 2010525831 A JP2010525831 A JP 2010525831A JP 2010525831 A JP2010525831 A JP 2010525831A JP 2010539901 A5 JP2010539901 A5 JP 2010539901A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- line
- composition
- response
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 18
- 229920001184 polypeptide Polymers 0.000 claims 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims 17
- 230000002163 immunogen Effects 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 210000000265 leukocyte Anatomy 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 125000003729 nucleotide group Chemical group 0.000 claims 5
- 241000725303 Human immunodeficiency virus Species 0.000 claims 4
- 210000001744 T-lymphocyte Anatomy 0.000 claims 4
- 241000700605 Viruses Species 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 230000001717 pathogenic effect Effects 0.000 claims 4
- 206010038997 Retroviral infections Diseases 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 230000005867 T cell response Effects 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 230000016396 cytokine production Effects 0.000 claims 2
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 claims 2
- 239000013598 vector Substances 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 108010002459 HIV Integrase Proteins 0.000 claims 1
- 108010010369 HIV Protease Proteins 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 229940035032 monophosphoryl lipid a Drugs 0.000 claims 1
- 229940042402 non-nucleoside reverse transcriptase inhibitor Drugs 0.000 claims 1
- 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97399307P | 2007-09-20 | 2007-09-20 | |
| PCT/US2008/010883 WO2009038756A2 (en) | 2007-09-20 | 2008-09-19 | Long interspersed nuclear element polypeptide compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010539901A JP2010539901A (ja) | 2010-12-24 |
| JP2010539901A5 true JP2010539901A5 (enExample) | 2011-10-27 |
Family
ID=40468692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525831A Pending JP2010539901A (ja) | 2007-09-20 | 2008-09-19 | 長鎖散在反復配列ポリペプチド組成物およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110046042A1 (enExample) |
| EP (1) | EP2200637A4 (enExample) |
| JP (1) | JP2010539901A (enExample) |
| KR (1) | KR20100075483A (enExample) |
| CN (1) | CN101969987A (enExample) |
| AU (1) | AU2008301888A1 (enExample) |
| BR (1) | BRPI0817209A2 (enExample) |
| CA (1) | CA2700115A1 (enExample) |
| MX (1) | MX2010003110A (enExample) |
| RU (1) | RU2010115088A (enExample) |
| WO (1) | WO2009038756A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| CA2822302A1 (en) | 2006-02-13 | 2007-08-23 | Alethia Biotherapeutics Inc. | Methods of impairing osteoclast differentiation |
| US8647640B2 (en) | 2009-06-24 | 2014-02-11 | Richard E. COWART | Vaccine compositions and methods of use to protect against infectious disease |
| US20140031250A1 (en) * | 2010-10-07 | 2014-01-30 | David Tsai Ting | Biomarkers of Cancer |
| US20150219662A1 (en) * | 2012-06-28 | 2015-08-06 | University Of Louisville Research Foundation, Inc. | Use of protein line-1 orf-1 as a biomarker for cancer |
| WO2014012165A1 (en) | 2012-07-19 | 2014-01-23 | Alethia Biotherapeutics Inc. | Anti-siglec-15 antibodies |
| WO2015200697A1 (en) | 2014-06-25 | 2015-12-30 | The General Hospital Corporation | Targeting human satellite ii (hsatii) |
| WO2016159377A1 (ja) * | 2015-04-03 | 2016-10-06 | 国立大学法人京都大学 | がんの治療薬のスクリーニング方法 |
| GB201507030D0 (en) * | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| EP4045655A4 (en) * | 2019-10-16 | 2024-02-28 | King Abdullah University Of Science And Technology | Methods for modulating human l1 retrotransposons rna and compositions for use therein |
| WO2021134040A2 (en) * | 2019-12-26 | 2021-07-01 | The Johns Hopkins University | Enhancing expression of line-1 encoded orf2p for cancer therapeutics |
| WO2021246265A1 (ja) | 2020-06-02 | 2021-12-09 | 学校法人東京女子医科大学 | Ｓ１００ａ８阻害ペプチドとこれを含む疾患治療薬 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280108A (en) * | 1991-09-27 | 1994-01-18 | United States Of America | Antibodies to p40 |
| JP4125784B2 (ja) * | 1995-10-20 | 2008-07-30 | ユニバーシティ・オブ・ネブラスカ・ボード・オブ・リージェンツ | 抗原提示細胞により仲介される免疫応答を高めるための組成物および方法 |
| CN1315332A (zh) * | 2000-03-27 | 2001-10-03 | 上海博德基因开发有限公司 | 一种新的多肽——l1－12和编码这种多肽的多核苷酸 |
| CN1315379A (zh) * | 2000-03-27 | 2001-10-03 | 上海博德基因开发有限公司 | 一种新的多肽——人L1因子p40蛋白12和编码这种多肽的多核苷酸 |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US7700359B2 (en) * | 2000-06-02 | 2010-04-20 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells |
| CN1339478A (zh) * | 2000-08-21 | 2002-03-13 | 上海博德基因开发有限公司 | 一种新的多肽——人l1因子orf2相关蛋白10.78和编码这种多肽的多核苷酸 |
| CN1339450A (zh) * | 2000-08-21 | 2002-03-13 | 上海博德基因开发有限公司 | 一种新的多肽——转座元蛋白14.41和编码这种多肽的多核苷酸 |
| CN1343776A (zh) * | 2000-09-19 | 2002-04-10 | 上海博德基因开发有限公司 | 一种新的多肽——dna聚合酶9.02和编码这种多肽的多核苷酸 |
| CN1352094A (zh) * | 2000-11-06 | 2002-06-05 | 上海博德基因开发有限公司 | 一种新的多肽——人l1元件类蛋白19.80和编码这种多肽的多核苷酸 |
| CN1425684A (zh) * | 2001-12-19 | 2003-06-25 | 复旦大学 | 一种多肽——人反转录转座40蛋白－12.76和编码这种多肽的多核苷酸 |
| AU2003294236A1 (en) * | 2002-10-25 | 2004-05-25 | Five Prime Therapeutics, Inc. | Methods of use for novel human polypeptides encoded by polynucleotides |
| WO2005012502A2 (en) * | 2003-03-28 | 2005-02-10 | Idm Pharma, Inc. | Methods of identifying optimal variants of peptide epitopes |
| AU2004291828B2 (en) * | 2003-05-28 | 2010-09-23 | The Johns Hopkins University | Synthetic mammalian retrotransposon gene |
-
2008
- 2008-09-19 WO PCT/US2008/010883 patent/WO2009038756A2/en not_active Ceased
- 2008-09-19 MX MX2010003110A patent/MX2010003110A/es not_active Application Discontinuation
- 2008-09-19 CN CN2008801164478A patent/CN101969987A/zh active Pending
- 2008-09-19 RU RU2010115088/15A patent/RU2010115088A/ru unknown
- 2008-09-19 KR KR1020107007557A patent/KR20100075483A/ko not_active Withdrawn
- 2008-09-19 BR BRPI0817209-9A2A patent/BRPI0817209A2/pt not_active Application Discontinuation
- 2008-09-19 EP EP08832080A patent/EP2200637A4/en not_active Withdrawn
- 2008-09-19 JP JP2010525831A patent/JP2010539901A/ja active Pending
- 2008-09-19 CA CA2700115A patent/CA2700115A1/en not_active Abandoned
- 2008-09-19 AU AU2008301888A patent/AU2008301888A1/en not_active Abandoned
- 2008-09-19 US US12/677,278 patent/US20110046042A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010539901A5 (enExample) | ||
| JP7551157B2 (ja) | Ｈｉｖワクチン接種および免疫療法 | |
| RU2010115088A (ru) | Композиции на основе line-полипептида и способы их применения | |
| JP2012509340A5 (enExample) | ||
| JP2024099855A (ja) | Ｈｉｖ予備免疫化および免疫療法 | |
| JP2014534202A5 (enExample) | ||
| CN106999571B (zh) | 诱导针对人免疫缺陷病毒感染的保护性免疫性的方法和组合物 | |
| JP2009544614A5 (enExample) | ||
| JP2019526580A5 (enExample) | ||
| JP2025098175A (ja) | 事前の免疫化ステップのないｈｉｖ免疫療法 | |
| JP2015529678A5 (enExample) | ||
| JP2016534034A5 (enExample) | ||
| JP2019527055A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| JP2010500399A5 (enExample) | ||
| JP2006020648A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| Alfano et al. | New players in cytokine control of HIV infection | |
| EA201591213A1 (ru) | Вакцины против вируса гепатита b | |
| JP2017501986A5 (ja) | 二重特異性ｈｉｖ−１中和抗体 | |
| JP2008526764A5 (enExample) | ||
| JP2015514132A (ja) | ヒト呼吸器合胞体ウイルスコンセンサス抗原、核酸構築物、およびそれらから作製されるワクチン、ならびにその使用方法 | |
| JP2011517409A (ja) | レンチウイルスベースの免疫原性ベクター | |
| JP2014509838A5 (enExample) | ||
| RU2011138160A (ru) | Пептиды foxmi и вакцины, содержащие их |